# Advanced Research in Neuroprotection

**Authors:** Christos Bakirtzis, Evangelia Kesidou

PMC · DOI: 10.3390/biomedicines14020450 · Biomedicines · 2026-02-17

## Full-text entities

- **Genes:** HLA-A (major histocompatibility complex, class I, A) [NCBI Gene 3105] {aka HLAA}
- **Diseases:** glioblastoma (MESH:D005909), multiple sclerosis (MESH:D009103), neuromyelitis optica spectrum disorder (MESH:D009471), neuronal damage (MESH:D009410), tauopathies (MESH:D024801), neurological disorders (MESH:D009461), Inflammatory, immune-mediated diseases (MESH:C567355), motor neuron diseases (MESH:D016472), neurological diseases (MESH:D020271), synucleinopathies (MESH:D000080874), neural damage (MESH:D015441), Alzheimer's disease (MESH:D000544), tumor (MESH:D009369), cerebral ischemia (MESH:D002545), inflammatory (MESH:D007249), neurodegenerative diseases (MESH:D019636), injury to (MESH:D014947)
- **Chemicals:** selenium (MESH:D012643), sildenafil (MESH:D000068677), thiamine pyrophosphate (MESH:D013835)
- **Species:** Homo sapiens (human, species) [taxon 9606]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12938207/full.md

## References

17 references — full list in the complete paper: https://tomesphere.com/paper/PMC12938207/full.md

---
Source: https://tomesphere.com/paper/PMC12938207